This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 97/11/1152    most recent 01.RES.0000193598.89753.e3v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mankodi, A. Articles by Thornton, C. A. Search for Related Content PubMed PubMed Citation Articles by Mankodi, A. Articles by Thornton, C. A. Related Collections Cell biology/structural biology Gene expression Genetics of cardiovascular disease

(Circulation Research. 2005;97:1152.)
© 2005 American Heart Association, Inc.

Cellular Biology

Nuclear RNA Foci in the Heart in Myotonic Dystrophy

Ami Mankodi, Xiaoyan Lin, Burns C. Blaxall, Maurice S. Swanson, Charles A. Thornton

From the Departments of Neurology (A.M., C.A.T.), Neuroscience (X.L.), and Cardiovascular Research Institute (B.C.B.), University of Rochester Medical Center, New York; and the Department of Molecular Genetics and Microbiology (M.S.S.), University of Florida, Gainesville.

Correspondence to Charles A. Thornton, MD, Department of Neurology, Box 673, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY 14642. E-mail Charles_Thornton{at}URMC.Rochester.Edu

The disease mechanism underlying myotonic dystrophy type 1 (DM1) pathogenesis in skeletal muscle may involve sequestration of RNA binding proteins in nuclear foci of expanded poly(CUG) RNA. Here we report evidence for a parallel mechanism in the heart. Accumulation of expanded poly(CUG) RNA in nuclear foci is associated with sequestration of muscleblind proteins and abnormal regulation of alternative splicing in DM1 cardiac muscle. A toxic effect of RNA with an expanded repeat may contribute to cardiac disease in DM1.

Key Words: myotonic dystrophy • CUG repeats • RNA foci • muscleblind • alternative splicing

This article has been cited by other articles:

				I. Holt, V. Jacquemin, M. Fardaei, C. A. Sewry, G. S. Butler-Browne, D. Furling, J. D. Brook, and G. E. Morris Muscleblind-Like Proteins: Similarities and Differences in Normal and Myotonic Dystrophy Muscle Am. J. Pathol., January 1, 2009; 174(1): 216 - 227. [Abstract] [Full Text] [PDF]

				K. Usdin The biological effects of simple tandem repeats: Lessons from the repeat expansion diseases Genome Res., July 1, 2008; 18(7): 1011 - 1019. [Abstract] [Full Text] [PDF]

				M. Nakamori, T. Kimura, T. Kubota, T. Matsumura, H. Sumi, H. Fujimura, M. P. Takahashi, and S. Sakoda Aberrantly spliced {alpha}-dystrobrevin alters {alpha}-syntrophin binding in myotonic dystrophy type 1 Neurology, February 26, 2008; 70(9): 677 - 685. [Abstract] [Full Text] [PDF]

				Y. Yuan, S. A. Compton, K. Sobczak, M. G. Stenberg, C. A. Thornton, J. D. Griffith, and M. S. Swanson Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs Nucleic Acids Res., August 15, 2007; (2007) gkm601v1. [Abstract] [Full Text] [PDF]

				R. J. Osborne and C. A. Thornton RNA-dominant diseases Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R162 - R169. [Abstract] [Full Text] [PDF]

				M. de Haro, I. Al-Ramahi, B. De Gouyon, L. Ukani, A. Rosa, N. A. Faustino, T. Ashizawa, T. A. Cooper, and J. Botas MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1 Hum. Mol. Genet., July 1, 2006; 15(13): 2138 - 2145. [Abstract] [Full Text] [PDF]